Johnson & Johnson is one of the world’s leading pharmaceutical companies.
Johnson & Johnson reported full year 2025 total revenues of $94.2 billion — a 6% increase — comprising approximately $60 billion from Innovative Medicine and $34 billion from MedTech. As a pure pharmaceutical and medical technology company following the 2023 separation of its consumer health business into Kenvue, J&J’s Innovative Medicine division now competes directly with Roche, AbbVie, and AstraZeneca as one of the three largest pharmaceutical companies by revenue. Darzalex for multiple myeloma continues growing at high double-digit rates.
This report provides comprehensive strategic intelligence on Johnson & Johnson — covering strategic directions, financial performance, SWOT analysis, technological know-how, latest products and services, M&A, marketing tactics, and organization and management.
This report provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs.
Topics Covered
• Financial performance 2023-2025
• SWOT analysis
• Technological know-how and key platforms
• Latest products, programs, and innovation pipeline
• M&A activity 2023-2025
• Marketing tactics and commercial strategy
• Organization and management
Table of Contents
1. Executive Summary
2. Strategic Directions
3. Financial Performance
4. SWOT Analysis
5. Technological Know-How
6. Latest Products and Services
7. M&A
8. Marketing Tactics
9. Organization and Management
10. Appendix
List of Tables
Table 1. Johnson & Johnson — Key Financial Metrics 2023-2025
Table 2. Johnson & Johnson — Revenue by Therapeutic Area 2023-2025
Table 3. Johnson & Johnson — Revenue by Geography 2023-2025
Table 4. Johnson & Johnson — R&D Investment 2023-2025
Table 5. Johnson & Johnson — SWOT Analysis
Table 6. Johnson & Johnson — Key Technology Platforms
Table 7. Johnson & Johnson — Top Products by Revenue 2025
Table 8. Johnson & Johnson — Late-Stage Pipeline 2025
Table 9. Johnson & Johnson — M&A Activity 2023-2025
Table 10. Johnson & Johnson — Key Management
Table 11. Johnson & Johnson — Strategic Priorities 2025-2030
